About the Authors
- Alastair J. Noyce
-
Contributed equally to this work with: Alastair J. Noyce, Demis A. Kia
Affiliations Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom, Centre for Neuroscience and Trauma, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
- Demis A. Kia
-
Contributed equally to this work with: Alastair J. Noyce, Demis A. Kia
Affiliation Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom
- Gibran Hemani
-
Affiliations MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
- Aude Nicolas
-
Affiliation Laboratory for Neurogenetics, National Institute on Aging National Institutes of Health, Bethesda, Maryland, United States of America
- T. Ryan Price
-
Affiliation Laboratory for Neurogenetics, National Institute on Aging National Institutes of Health, Bethesda, Maryland, United States of America
- Eduardo De Pablo-Fernandez
-
Affiliation Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom
- Philip C. Haycock
-
Affiliations MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
- Patrick A. Lewis
-
Affiliations Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom, School of Pharmacy, University of Reading, Reading, United Kingdom
- Thomas Foltynie
-
Affiliation Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, University College London, London, United Kingdom
- George Davey Smith
-
Affiliations MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
- International Parkinson Disease Genomics Consortium
-
¶Membership of the International Parkinson Disease Genomics Consortium is provided in the Acknowledgments.
- Anette Schrag
-
Affiliation Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, United Kingdom
- Andrew J. Lees
-
Affiliation Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom
- John Hardy
-
Affiliation Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom
- Andrew Singleton
-
Affiliation Laboratory for Neurogenetics, National Institute on Aging National Institutes of Health, Bethesda, Maryland, United States of America
- Mike A. Nalls
-
Affiliations Laboratory for Neurogenetics, National Institute on Aging National Institutes of Health, Bethesda, Maryland, United States of America, Data Tecnica International, Glen Echo, Maryland, United States of America
- Neil Pearce
-
Affiliation Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, United Kingdom
- Debbie A. Lawlor
-
Affiliations MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
- Nicholas W. Wood
-
* E-mail: n.wood@ucl.ac.uk
Affiliation Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom
Competing Interests
AJN reports: grants from Parkinson’s UK, Élan/Prothena Pharmaceuticals, GE Healthcare; shares in LifeLab Ltd; advisory board membership for myHealthPal; honoraria from Office Octopus, Henry Stewart Talks, and Britannia Pharmaceuticals Ltd, all outside of the submitted work. PAL reports grants from MRC, BBSRC, National Institutes of Health, Michael J. Fox Foundation, personal fees from Astex Pharmaceuticals, outside the submitted work. TF reports grants from Michael J Fox Foundation, grants from Brain Research Trust, grants from European Union FP7, grants from John Black Charitable Foundation, personal fees from Medtronic, personal fees from BIAL, personal fees from Profile Pharma, personal fees from Brittania, all outside the submitted work. ASc reports grants from GE Healthcare, outside the submitted work. AJL reports personal fees from Britannia Pharmaceuticals Ltd, BIAL Portela, Profile Pharma Ltd, Teva, Lundbeck, Roche, UCB, NeuroDerm, Nordicinfu Care, Decision Resources, all outside of the submitted work. GDS is a member of the Editorial Board of PLOS Medicine. MAN is a paid consultant/contractor to the NIH. DAL reports grants from UK Medical Research Council, during the conduct of the study; grants from Medical Research council, grants from Wellcome Trust, grants from European Research Council, grants from Roche Diagnostics, grants from Medtronic, grants from Ferring Pharmaceuticals, outside the submitted work. DAK, GH, ASi, AN, EDP-F, JH, NP, TRP, NWW report no relevant disclosures.
Author Contributions
Conceptualization: AJN, DAK, JH, ASc, AJL, ASi, TF, MAN, NP, DAL, NWW. Data curation: AJN, DAK, GH, AN, TRP, EPF, PAL, GDS, DAL, MAN. Formal analysis: AJN, DAK, GH, MAN. Investigation: AJN, DAK, GH, MAN. Methodology: AJN, DAK, GH, PCH, GDS, MAN, DAL, NP, NWW. Software: GH, AN, TRP, MAN. Supervision: DAL, MAN, NWW. Validation: AJN, DAK. Writing – original draft: AJN, DAK, GH, GDS, DAL, NP, MAN, NWW. Writing – review & editing: AN, TRP, PCH, EPF, PAL, TF, ASc, AJL, ASi, PAL.